Astellas Urology Patient Program

In June 2018, Kos designed, developed, and implemented the Astellas Urology Patient Program through community pharmacies. The program was supported by Astellas Pharma Australia Pty. Ltd. in partnership with PharmaPrograms. Patients prescribed Betmiga® (mirabegron) and Vesicare® (solifenacin succinate) are able to participate in this Astellas Urology Patient Program.